CAR-NK,癌症的一个的策略,特别是对于妇科瘤
Yisen Cao1, Liying Wang2,3,4, Liang Wang3,4
1Fujian Medical University.
Immunity, inflammation and disease
|June 17, 2025
概括
化学抗原受体NK (CAR-NK) 细胞疗法在治疗固体瘤,特别是妇科癌症方面表现有前途. 在CAR-NK工程方面的创新提高了安全性和有效性,为目前的治疗提供了有希望的替代方案.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 自然杀手 (NK) 细胞是先天性淋巴细胞,不特定地杀死瘤细胞.
- 化学抗原受体 (CAR) 技术增强NK细胞的功能,以向瘤消除.
- CAR-NK细胞在血液恶性瘤中表现出有效性,但在固体瘤中面临挑战,包括妇科癌症.
研究的目的:
- 审查CAR-NK工程中的方法创新.
- 评估CAR-NK治疗对瘤向治疗的转化潜力.
- 为未来的临床试验和研究提供见解.
主要方法:
- 在电子数据库中进行系统的文献搜索 (PubMed, Web of Science).
- 关键词:CAR-NK细胞,化学抗原受体,固体瘤,细胞疗法,妇科癌症.
- 审查最近的方法创新和翻译潜力.
主要成果:
- 汽车NK的工程创新包括多目标的汽车设计和基因编辑,以提高持久性.
- 开发"现成"的CAR-NK细胞比CAR-T细胞具有优势.
- CAR-NK细胞显示出治疗固体瘤的潜力,包括妇科癌症.
结论:
- 卡尔-NK细胞疗法提供了安全性和抗瘤疗效的结合.
- CAR-NK疗法为妇科癌症治疗提供了一个有前途的替代方案.
- 需要进一步的研究和临床试验来优化CAR-NK的应用.
更多相关视频
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
3.4K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
816
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
